Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 1
1977 1
1978 2
1980 2
1981 2
1982 1
1983 1
1984 3
1985 4
1986 5
1987 4
1988 5
1989 2
1990 8
1991 8
1992 9
1993 18
1994 22
1995 26
1996 19
1997 23
1998 14
1999 24
2000 33
2001 40
2002 29
2003 57
2004 45
2005 52
2006 63
2007 63
2008 67
2009 72
2010 79
2011 78
2012 96
2013 96
2014 95
2015 100
2016 92
2017 82
2018 82
2019 88
2020 79
2021 74
2022 74
2023 44

Text availability

Article attribute

Article type

Publication date

PubMed for id: 858872

1,648 results

Results by year

Filters applied: . Clear all
Page 1
Methotrexate safety and efficacy in combination therapies in patients with early rheumatoid arthritis: a post-hoc analysis of a randomized controlled trial (NORD-STAR).
Lend K, Koopman FA, Lampa J, Jansen G, Hetland ML, Uhlig T, Nordström D, Nurmohamed M, Gudbjornsson B, Rudin A, Østergaard M, Heiberg MS, Sokka-Isler T, Hørslev-Petersen K, Haavardsholm EA, Grondal G, Twisk JWR, van Vollenhoven R. Lend K, et al. Arthritis Rheumatol. 2023 Oct 17. doi: 10.1002/art.42730. Online ahead of print. Arthritis Rheumatol. 2023. PMID: 37846618
A serum metabolic biomarker panel for early rheumatoid arthritis.
Rodríguez-Muguruza S, Altuna-Coy A, Arreaza-Gil V, Mendieta-Homs M, Castro-Oreiro S, Poveda-Elices MJ, Del Castillo-Piñol N, Fontova-Garrofé R, Chacón MR. Rodríguez-Muguruza S, et al. Front Immunol. 2023 Sep 1;14:1253913. doi: 10.3389/fimmu.2023.1253913. eCollection 2023. Front Immunol. 2023. PMID: 37720214 Free PMC article.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
Initial presentation of early rheumatoid arthritis.
Weman L, Salo H, Kuusalo L, Huhtakangas J, Kärki J, Vähäsalo P, Backström M, Sokka-Isler T. Weman L, et al. PLoS One. 2023 Jul 6;18(7):e0287707. doi: 10.1371/journal.pone.0287707. eCollection 2023. PLoS One. 2023. PMID: 37410796 Free PMC article.
1,648 results